Literature DB >> 1542652

Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

M A Pierotti1, M Santoro, R B Jenkins, G Sozzi, I Bongarzone, M Grieco, N Monzini, M Miozzo, M A Herrmann, A Fusco.   

Abstract

RET/PTC is a transforming sequence created by the fusion of the tyrosine kinase domain of the RET protooncogene with the 5' end of the locus D10S170 designated by probe H4 and is frequently found activated in human papillary thyroid carcinomas. RET and D10S170 have been mapped to contiguous regions of the long arm of chromosome 10: q11.2 and q21, respectively. To identify the mechanism leading to the generation of the oncogenic sequence RET/PTC, a combined cytogenetic and molecular analysis of several cases of papillary thyroid carcinomas was done. In four cases the results indicated that these tumors had RET/PTC activation and a paracentric inversion of the long arm of chromosome 10, inv(10)(q11.2q21), with breakpoints coincident with the regions where RET and D10S170 are located. Therefore, a chromosome 10q inversion provides the structural basis for the D10S170-RET fusion that forms the hybrid transforming sequence RET/PTC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542652      PMCID: PMC48503          DOI: 10.1073/pnas.89.5.1616

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.

Authors:  J R Testa; M Park; D G Blair; A Kalbakji; K Arden; G F Vande Woude
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

2.  Megabase inversions in the human genome as physiological events.

Authors:  G M Weichhold; H G Klobeck; R Ohnheiser; G Combriato; H G Zachau
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

Review 3.  Suppressors of the malignant phenotype.

Authors:  T Mikkelsen; W K Cavenee
Journal:  Cell Growth Differ       Date:  1990-04

4.  cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line.

Authors:  Y Ishizaka; T Ushijima; T Sugimura; M Nagao
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

5.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

6.  Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.

Authors:  R B Jenkins; I D Hay; J F Herath; C G Schultz; J L Spurbeck; C S Grant; J R Goellner; G W Dewald
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

7.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

8.  Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.

Authors:  G Sozzi; M A Pierotti; M Miozzo; R Donghi; P Radice; V De Benedetti; M Grieco; M Santoro; A Fusco; G Vecchio
Journal:  Oncogene       Date:  1991-02       Impact factor: 9.867

9.  Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice.

Authors:  T Iwamoto; M Takahashi; M Ito; M Hamaguchi; K Isobe; N Misawa; J Asai; T Yoshida; I Nakashima
Journal:  Oncogene       Date:  1990-04       Impact factor: 9.867

10.  The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A).

Authors:  R Donghi; G Sozzi; M A Pierotti; I Biunno; M Miozzo; A Fusco; M Grieco; M Santoro; G Vecchio; N K Spurr
Journal:  Oncogene       Date:  1989-04       Impact factor: 9.867

View more
  48 in total

1.  Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Authors:  Jennifer L Hunt; Zubair W Baloch; Leon Barnes; Patricia A Swalsky; Cindy L Trusky; E Sesatomi; Sydney Finkelstein; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder.

Authors:  Benjamin M Neale; Sarah Medland; Stephan Ripke; Richard J L Anney; Philip Asherson; Jan Buitelaar; Barbara Franke; Michael Gill; Lindsey Kent; Peter Holmans; Frank Middleton; Anita Thapar; Klaus-Peter Lesch; Stephen V Faraone; Mark Daly; Thuy Trang Nguyen; Helmut Schäfer; Hans-Christoph Steinhausen; Andreas Reif; Tobias J Renner; Marcel Romanos; Jasmin Romanos; Andreas Warnke; Susanne Walitza; Christine Freitag; Jobst Meyer; Haukur Palmason; Aribert Rothenberger; Ziarih Hawi; Joseph Sergeant; Herbert Roeyers; Eric Mick; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-08-05       Impact factor: 8.829

3.  Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma.

Authors:  X-P Qi; R-B Ying; J-M Ma; W-T Liu; Z-F Du; J Fei; C-P Yang; Q-Z Song; H-Y Jin; Z-G Chen; J-S Han; J-Q Wang; X-L Chen; Y Zhao; J-J Lu; X-N Zhang
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 4.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 5.  Translational research in endocrine surgery.

Authors:  Scott K Sherman; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2013-07-26       Impact factor: 3.495

6.  Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.

Authors:  I Bongarzone; N Monzini; M G Borrello; C Carcano; G Ferraresi; E Arighi; P Mondellini; G Della Porta; M A Pierotti
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 7.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

8.  Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.

Authors:  K Durick; G N Gill; S S Taylor
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

9.  Kinase expression and chromosomal rearrangements in papillary thyroid cancer tissues: investigations at the molecular and microscopic levels.

Authors:  H-U G Weier; J Kwan; C-M Lu; Y Ito; M Wang; A Baumgartner; S W Hayward; J F Weier; H F Zitzelsberger
Journal:  J Physiol Pharmacol       Date:  2009-10       Impact factor: 3.011

10.  RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation.

Authors:  Eunah Shin; Woung Youn Chung; Woo Ick Yang; Cheong Soo Park; Soon Won Hong
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.